We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,518

NRD Capital Management’s Strategy and Focus: Q&A With Susan Beth
  • McGuireWoods LLP
  • USA
  • September 14 2017

NRD Capital is focused on investing in multi-location, franchise concepts with superior productsservices and compelling unit economics across


International News: Focus on Health Care - Fall 2017
  • McDermott Will & Emery
  • European Union, United Kingdom, USA
  • September 8 2017

Health care systems across the world are facing similar challenges, regardless of their regulatory or cultural differences. From this however


Private Equity Investments in Health Care Practices
  • Pepper Hamilton LLP
  • USA
  • August 28 2017

Private equity funds are generally prohibited from owning entities that employ licensed professionals and may not invest directly in medical or dental


Formulas for Successful US Investing Investing in the US Health Care Sector
  • Mayer Brown
  • USA
  • August 14 2017

The US health care sector is expanding and presents a good number of opportunities for investors. There are a number of key legal considerations that


Private Equity Summary Report-July 2017
  • Benesch Friedlander Coplan & Aronoff LLP
  • USA
  • August 10 2017

At the midpoint of 2017, deal data suggests deal volume (both PE and M&A) continues to trend downward a trend that started in 2016 however, despite


FDA breaks with SBA on small business affiliation
  • Husch Blackwell LLP
  • USA
  • August 9 2017

Small business status impacts government contractors in several ways. Set-aside procurements and financial assistance programs are available for small


Healthcare deals flourish, but uncertainty looms large
  • White & Case LLP
  • USA
  • July 31 2017

Dealmaking in the pharmaceuticals and healthcare sector saw a rebound in H1 2017, with deal value increasing 51.8 percent compared to the preceding


2017 Mid-Year Securities Litigation and Enforcement Highlights
  • Baker & Hostetler LLP
  • USA
  • July 31 2017

The purpose of this report is to provide a periodic survey - in addition to our Practice Team Executive Alerts - on matters we believe to be of


Health Care Mergers: Four Key Pieces of Evidence Used to Predict The Future
  • Winston & Strawn LLP
  • USA
  • July 26 2017

The federal government challenges proposed mergers through Section 7 of the Clayton Act, which prohibits any acquisition within the realm of commerce


What IP Diligence is Due
  • Ropes & Gray LLP
  • USA
  • July 19 2017

Intellectual property due diligence can be practiced in a variety of transactional contexts including mergers and acquisitions, licensing, initial